Regulatory T cells and systemic autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome;Lymphocytes T régulateurs et maladies auto-immunes systémiques: Lupus érythémateux systémique, polyarthrite rhumatoïde et syndrome de Gougerot-Sjögren primaire

Revue de Medecine Interne

Volumn 31, Issue 2, 2010, Pages 116-127

  Bernard, F ^a,b   Romano, A ^b   Granel, B ^a,b  

^a HÔPITAL NORD   (France)

^b Aix Marseille university   (France)

Author keywords

Human; Primary Sj gren's syndrome; Regulatory T lymphocytes; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

ADALIMUMAB; CD4 ANTIGEN; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR INHIBITOR;

AUTOIMMUNE DISEASE; BIOLOGICAL THERAPY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; DRUG MECHANISM; EFFECTOR CELL; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SHORT SURVEY; SJOEGREN SYNDROME; SYNOVIAL FLUID; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD; ANTIGENS, CD4; ARTHRITIS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; SJOGREN'S SYNDROME; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 75549084387     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.03.364     Document Type: Short Survey

References (109)

1. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
2. Van Parijs L., Abbas A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998, 280:243-248.
3. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006, 212:28-50.
4. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001, 182:207-214.
5. Sakaguchi S. Regulatory T cells in the past and for the future. Eur J Immunol 2008, 38:901-937.
6. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005, 6:345-352.
7. Belkaid Y. Role of Foxp3-positive regulatory T cells during infection. Eur J Immunol 2008, 38:918-921.
8. Gershon R.K., Kondo K. Infectious immunological tolerance. Immunology 1971, 21:903-914.
9. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
10. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001, 193:1285-1294.
11. Stephens L.A., Mottet C., Mason D., Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001, 31:1247-1254.
12. Horwitz D.A., Zheng S.G., Wang J., Gray J.D. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 2008, 38:912-915.
13. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005, 6:331-337.
14. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
15. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., Verbsky J.W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 2007, 119:482-487.
16. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
17. Brusko T., Bluestone J. Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation. Eur J Immunol 2008, 38:931-934.
18. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
19. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
20. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
21. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
22. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
23. Polansky J.K., Kretschmer K., Freyer J., Floess S., Garbe A., Baron U., et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008, 38:1654-1663.
24. Wang J., Ioan-Facsinay A., van der Voort E.I., Huizinga T.W., Toes R.E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 2007, 37:129-138.
25. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006, 203:1701-1711.
26. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
27. Pillai V., Ortega S.B., Wang C.K., Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007, 123:18-29.
28. Banham A.H. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol 2006, 27:541-544.
29. Wan Y.Y., Flavell R.A. TGF-beta and Regulatory T Cell in Immunity and Autoimmunity. J Clin Immunol 2008.
30. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
31. Bardel E., Larousserie F., Charlot-Rabiega P., Coulomb-L'Hermine A., Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol 2008, 181:6898-6905.
32. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
33. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
34. Huter E.N., Punkosdy G.A., Glass D.D., Cheng L.I., Ward J.M., Shevach E.M. TGF-beta-induced Foxp3(+) regulatory T cells rescue scurfy mice. Eur J Immunol 2008, 38:1814-1821.
35. Crispin J.C., Martinez A., Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003, 21:273-276.
36. Fathy A., Mohamed R.W., Tawfik G.A., Omar A.S. Diminished CD4+CD25+ T-lymphocytes in peripheral blood of patients with systemic lupus erythematosus. Egypt J Immunol 2005, 12:25-31.
37. Lee J.H., Wang L.C., Lin Y.T., Yang Y.H., Lin D.T., Chiang B.L. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006, 117:280-286.
38. Liu M.F., Wang C.R., Fung L.L., Wu C.R. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004, 59:198-202.
39. Lee H.Y., Hong Y.K., Yun H.J., Kim Y.M., Kim J.R., Yoo W.H. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 2008, 47:789-794.
40. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
41. Mellor-Pita S., Citores M.J., Castejon R., Tutor-Ureta P., Yebra-Bango M., Andreu J.L., et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 2006, 65:553-554.
42. Bonelli M., Savitskaya A., von Dalwigk K., Steiner C.W., Aletaha D., Smolen J.S., et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 2008, 20:861-868.
43. Zhang B., Zhang X., Tang F.L., Zhu L.P., Liu Y., Lipsky P.E. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis 2008, 67:1037-1040.
44. Vargas-Rojas M.I., Crispin J.C., Richaud-Patin Y., Alcocer-Varela J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 2008, 17:289-294.
45. Yates J., Whittington A., Mitchell P., Lechler R.I., Lightstone L., Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 2008, 153:44-55.
46. Azab N.A., Bassyouni I.H., Emad Y., Abd El-Wahab G.A., Hamdy G., Mashahit M.A. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol 2008, 127:151-157.
47. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., Baranda L., Layseca-Espinosa E., Abud-Mendoza C., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006, 27:110-118.
48. Suarez A., Lopez P., Gomez J., Gutierrez C. Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 2006, 65:1512-1517.
49. Valencia X., Yarboro C., Illei G., Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
50. Venigalla R.K., Tretter T., Krienke S., Max R., Eckstein V., Blank N., et al. Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008, 58:2120-2130.
51. Hu S., Xiao W., Kong F., Ke D., Qin R., Su M. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus. J Huazhong Univ Sci Technolog Med Sci 2008, 28:549-552.
52. Banica L., Besliu A., Pistol G., Stavaru C., Ionescu R., Forsea A.M., et al. Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 2009, 42:41-49.
53. Lin S.C., Chen K.H., Lin C.H., Kuo C.C., Ling Q.D., Chan C.H. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 2007, 37:987-996.
54. Zhang B., Zhang X., Tang F., Zhu L., Liu Y. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 2008, 153:182-187.
55. Yan B., Ye S., Chen G., Kuang M., Shen N., Chen S. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 2008, 58:801-812.
56. Barath S., Aleksza M., Tarr T., Sipka S., Szegedi G., Kiss E. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus 2007, 16:489-496.
57. Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology2009 ;127(2):196-205.
58. Lyssuk E.Y., Torgashina A.V., Soloviev S.K., Nassonov E.L., Bykovskaia S.N. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007, 601:113-119.
59. Bonelli M., Savitskaya A., Steiner C.W., Rath E., Smolen J.S., Scheinecker C. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol 2009, 182:1689-1695.
60. Fields M.L., Hondowicz B.D., Wharton G.N., Adair B.S., Metzgar M.H., Alexander S.T., et al. The regulation and activation of lupus-associated B cells. Immunol Rev 2005, 204:165-183.
61. Liu Y., Zhang P., Li J., Kulkarni A.B., Perruche S., Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008, 9:632-640.
62. Tsokos G.C., Mitchell J.P., Juang Y.T. T cell abnormalities in human and mouse lupus: intrinsic and extrinsic. Curr Opin Rheumatol 2003, 15:542-547.
63. Miyara M., Amoura Z., Piette J.C., Gorochov G. Cellules T régulatrices et lupus érythémateux systémique. Rev Med Interne 2008, 29:691-695.
64. Cepika A.M., Marinic I., Morovic-Vergles J., Soldo-Juresa D., Gagro A. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up. Lupus 2007, 16:374-377.
65. Liossis S.N., Sfikakis P.P. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol 2008, 127:280-285.
66. Sutmuller R., Garritsen A., Adema G.J. Regulatory T cells and toll-like receptors: regulating the regulators. Ann Rheum Dis 2007, 66(Suppl. 3):iii91-iii95.
67. Mudd P.A., Teague B.N., Farris A.D. Regulatory T cells and systemic lupus erythematosus. Scand J Immunol 2006, 64:211-218.
68. Cao D., Malmstrom V., Baecher-Allan C., Hafler D., Klareskog L., Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003, 33:215-223.
69. Liu M.F., Wang C.R., Fung L.L., Lin L.H., Tsai C.N. The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 2005, 62:312-317.
70. Mottonen M., Heikkinen J., Mustonen L., Isomaki P., Luukkainen R., Lassila O. CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005, 140:360-367.
71. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004, 200:277-285.
72. Vigna-Perez M., Abud-Mendoza C., Portillo-Salazar H., Alvarado-Sanchez B., Cuevas-Orta E., Moreno-Valdes R., et al. Immune effects of therapy with adalimumab in patients with rheumatoid arthritis. Clin Exp Immunol 2005, 141:372-380.
73. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype and function between peripheral blood and synovial fluid. Arthritis Rheum 2004, 50:2775-2785.
74. Liu M.F., Wang C.R., Chen P.C., Fung L.L. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol 2003, 57:568-572.
75. Aerts N.E., Dombrecht E.J., Ebo D.G., Bridts C.H., Stevens W.J., De Clerck L.S. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis. Cell Immunol 2008, 251:109-115.
76. Cao D., van Vollenhoven R., Klareskog L., Trollmo C., Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004, 6:R335-R346.
77. Lawson C.A., Brown A.K., Bejarano V., Douglas S.H., Burgoyne C.H., Greenstein A.S., et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006, 45:1210-1217.
78. Toubi E., Kessel A., Mahmudov Z., Hallas K., Rozenbaum M., Rosner I. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab. Ann N Y Acad Sci 2005, 1051:506-514.
79. Jiao Z., Wang W., Jia R., Li J., You H., Chen L., et al. Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007, 36:428-433.
80. Dombrecht E.J., Aerts N.E., Schuerwegh A.J., Hagendorens M.M., Ebo D.G., Van Offel J.F., et al. Influence of anti-tumor necrosis factor therapy (adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Clin Exp Rheumatol 2006, 24:31-37.
81. Kao J.K., Hsue Y.T., Lin C.Y. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients. J Microbiol Immunol Infect 2007, 40:419-427.
82. Han G.M., O'Neil-Andersen N.J., Zurier R.B., Lawrence D.A. CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol 2008, 253:92-101.
83. Yudoh K., Matsuno H., Nakazawa F., Yonezawa T., Kimura T. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum 2000, 43:617-627.
84. van Amelsfort J.M., van Roon J.A., Noordegraaf M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., et al. Proinflammatory mediator-induced reversal of CD4+, CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007, 56:732-742.
85. Cao D., Borjesson O., Larsson P., Rudin A., Gunnarsson I., Klareskog L., et al. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scand J Immunol 2006, 63:444-452.
86. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001, 194:847-853.
87. Salmon M., Scheel-Toellner D., Huissoon A.P., Pilling D., Shamsadeen N., Hyde H., et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997, 99:439-446.
88. Valencia X., Stephens G., Goldbach-Mansky R., Wilson M., Shevach E.M., Lipsky P.E. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006, 108:253-261.
89. Flores-Borja F., Jury E.C., Mauri C., Ehrenstein M.R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A 2008, 105:19396-19401.
90. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
91. Li J., Shen W., Kong K., Liu Z. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol 2006, 64:515-522.
92. Behrens F., Himsel A., Rehart S., Stanczyk J., Beutel B., Zimmermann S.Y., et al. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 2007, 66:1151-1156.
93. Nadkarni S., Mauri C., Ehrenstein M.R. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007, 204:33-39.
94. Wang J., van Dongen H., Scherer H.U., Huizinga T.W., Toes R.E. Suppressor activity among CD4+, CD25++ T cells is discriminated by membrane-bound tumor necrosis factor alpha. Arthritis Rheum 2008, 58:1609-1618.
95. Li X., Qian L., Wang G., Zhang H., Wang X., Chen K., et al. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjogren's syndrome. J Rheumatol 2007, 34:2438-2445.
96. Gottenberg J.E., Lavie F., Abbed K., Gasnault J., Le Nevot E., Delfraissy J.F., et al. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J Autoimmun 2005, 24:235-242.
97. Liu M.F., Lin L.H., Weng C.T., Weng M.Y. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome. Lupus 2008, 17:34-39.
98. Christodoulou M.I., Kapsogeorgou E.K., Moutsopoulos N.M., Moutsopoulos H.M. Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol 2008, 173:1389-1396.
99. Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002, 46:741-747.
100. Zintzaras E., Voulgarelis M., Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005, 165:2337-2344.
101. Mittal S., Marshall N.A., Duncan L., Culligan D.J., Barker R.N., Vickers M.A. Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood 2008, 111:5359-5370.
102. Gregg R., Smith C.M., Clark F.J., Dunnion D., Khan N., Chakraverty R., et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol 2005, 140:540-546.
103. Lages C.S., Suffia I., Velilla P.A., Huang B., Warshaw G., Hildeman D.A., et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008, 181:1835-1848.
104. Dejaco C., Duftner C., Schirmer M. Are regulatory T-cells linked with aging?. Exp Gerontol 2006, 41:339-345.
105. Rosenkranz D., Weyer S., Tolosa E., Gaenslen A., Berg D., Leyhe T., et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol 2007, 188:117-127.
106. Tsaknaridis L., Spencer L., Culbertson N., Hicks K., LaTocha D., Chou Y.K., et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003, 74:296-308.
107. Baecher-Allan C.M., Hafler D.A. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol 2005, 115:10-18.
108. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7:585-598.
109. Boissier M.C., Assier E., Biton J., Denys A., Falgarone G., Bessis N. Regulatory T cells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009, 76:10-14.